Fulgent Genetics Announces Potential Pricing For IPO
Published: Sep 29, 2016
Fulgent Genetics has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its IPO. The company expects to offer 4.6 million shares in an expected price range of $12 to $14 per share, with an overallotment option for an additional 690,000 shares. At the maximum price, the entire offering is valued up to $74.06 million. The company intends to list its shares on the Nasdaq under the symbol FLGT.